scholarly journals TRENDS AND SHORT-TERM OUTCOMES WITH THE USE OF CEREBRAL EMBOLIC PROTECTION DEVICE IN PATIENTS UNDERGOING TAVR

2021 ◽  
Vol 77 (18) ◽  
pp. 1166
Author(s):  
Aaqib Malik ◽  
Syed Zaid ◽  
Alexandros Briasoulis ◽  
Tomo Ando ◽  
Steven Lansman ◽  
...  
Keyword(s):  
Protection Device ◽  
Short Term ◽  
Embolic Protection Device ◽  
Embolic Protection

Abstract P540: Safety of Carotid Artery Stenting Without Embolic Protection: A Single Centre Experience

Stroke ◽  
2021 ◽  
Vol 52 (Suppl_1) ◽  
Author(s):  
Christine Hawkes ◽  
Aviraj Deshmukh ◽  
Brian van Adel
Keyword(s):  
Ischemic Stroke ◽  
Carotid Artery ◽  
Carotid Artery Stenting ◽  
Atheromatous Plaque ◽  
Stroke Rate ◽  
Protection Device ◽  
Single Centre ◽  
Stent Occlusion ◽  
Embolic Protection Device ◽  
Embolic Protection

Introduction: One of the most feared complications of carotid revascularization, including carotid artery stenting (CAS), is peri-procedural ischemic stroke. Several studies suggest that the use of a distal embolic protection device (EPD), as well as over-sized pre- and post-stenting balloon angioplasty, may increase the risk of dislodgement of atheromatous plaque in patients undergoing CAS. The CREST trial, that mandated the use of an EPD, had a peri-procedural ischemic stroke rate of 4.1%. We hypothesize that our technique of stenting without the use of an EPD and sub-maximal angioplasty will have a low risk of peri-procedural complications. Methods: A retrospective review was conducted of consecutive cases of ICA stenting without use of an embolic protection device between January 2012 and June 2020 at a Canadian stroke centre. Data was extracted from the patient electronic medical record and Picture Archives and Communications Systems (PACS). Both symptomatic and asymptomatic CAS cases were included. Results: A total of 220 patients were included in the study, with a median age of 70 years (range 39-93 years), and 83 patients (38%) were female. The vast majority of patients were symptomatic (216 patients [98%]). A large portion of patients had a contralateral ICA occlusion or near occlusion (56 patients [25%]). In the majority of cases, a Precise Cordis RX carotid stent (Cordis) was placed. There were four patients with peri-procedural ischemic strokes (1.8%), with two occurring 8-30 days after stenting. There was one case of acute stent occlusion associated with an ischemic stroke. Two patients (less than 1%) had hyperperfusion syndrome after CAS. Median length of stay following the procedure was one day. Conclusions: In this single centre series, the peri-procedural risks of CAS without using an EPD are low. The ischemic stroke rate is less than 2%, lower than what has been reported in large randomized controlled trials using embolic protection.

Embolic Protection Device

2018 ◽  
pp. 39-41
Author(s):  
Huajuan Mao ◽  
Junmin Bao ◽  
Yu Xiao
Keyword(s):  
Protection Device ◽  
Embolic Protection Device ◽  
Embolic Protection

Use of a Dual-Filter Embolic Protection Device for Brachiocephalic Artery Stenting

2020 ◽  
Vol 65 ◽  
pp. 282.e13-282.e15
Author(s):  
Awail Sadiq ◽  
Andrew M. Goldsweig ◽  
Edward L. O'Leary
Keyword(s):  
Brachiocephalic Artery ◽  
Protection Device ◽  
Embolic Protection Device ◽  
Embolic Protection
Sign in / Sign up

Export Citation Format

Share Document